Market Research Report
Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021
|Published by||MarketsandMarkets||Product code||325609|
|Published||Content info||137 Pages
|Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021|
|Published: August 15, 2016||Content info: 137 Pages||
The hemodynamic monitoring systems market is projected to reach USD 1,143.7 million by 2021 from USD 925.2 million in 2016, growing at a CAGR of 4.3% during the forecast period. Factors such as rising prevalence of diabetes and cardiovascular diseases, technological advancements, initiatives adopted by industry players, and rising aging population are driving the growth of the hemodynamic monitoring systems market.
Hemodynamic monitoring is the measurement of blood circulation and cardiac functions. It allows doctors to evaluate whether enough oxygen is being delivered to the organs and tissues. Healthcare providers use this information to detect changes or problems in a patient's health.
The disposables segment is expected to account for the largest share of the hemodynamic monitoring systems market, by product, in 2016. Hemodynamic disposables form an integral part of hemodynamic monitoring to determine the hemodynamic parameters in critically ill patients, thus attributing to the large share of the segment.
The invasive monitoring systems segment is expected to account for the largest share of the hemodynamic monitoring systems market, by type, in 2016. The large share of this segment is mainly attributed to the increasing utilization of invasive hemodynamic monitoring systems in both intensive care units (ICUs) and operating theaters (OTs) for the monitoring of patients with critical illnesses and hemodynamic instability.
The hospitals segment is expected to account for the largest share of the global hemodynamic monitoring systems market, by end user, in 2016. The large share of this segment is mainly attributed to the rising aging population and increasing prevalence of diseases such as cardiovascular and diabetes.
North America is expected to account for the largest share of the hemodynamic monitoring systems market in 2016, followed by Asia-Pacific, Europe, and the Rest of the World (RoW). The large share of the North American region can be attributed to technological advancements, initiatives adopted by industry players to boost the demand of hemodynamic monitoring systems in the U.S., and prevalence of high diabetes in Canada propels the market for Hemodynamic Monitoring Systems in North America. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the rapidly aging population in India and China and the high prevalence of diabetes in Vietnam, Singapore, Malaysia, China, and India.
The hemodynamic monitoring systems market is highly competitive, as there are several big and small firms with similar product offerings. These companies adopt various strategies (mergers and acquisitions; agreements, partnerships, collaborations, and joint ventures; new product launches, funding, and FDA approvals; and marketing & promotion) to increase their shares and establish a stronger foothold in the global hemodynamic monitoring systems market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.